Cancer drugs could enter clinical trials and ultimately reach cancer patients faster thanks to legal contract templates created by the CEO Roundtable on Cancer.
Johnson & Johnson has tapped Chinese WuXi PharmaTech for additional R&D services, following the trend towards high-level, strategic collaborations between drugmakers and contract research organisations.
Tepnel Life Sciences has expanded its pharmaceutical services offering by becoming the UK’s first genetic analysis services provider to use Illumina’s next-generation iScan system.
Wyeth Medica, an Irish subsidiary of US drugmaker Wyeth, plans to cut 250 jobs at its manufacturing plant in Newbridge, County Kildare, according to media reports.
The relentless commoditisation of glycerine ingredients prompted Dow Chemicals to all but exit the sector a few years back, but now the company says it is seeing a resurgence for its flagship synthetic glycerine brand.
Gerresheimer’s decision to concentrate on the pharmaceutical and life science sectors and sell-off non-core divisions appears to be paying dividends judging by a 14 per cent jump in third quarter operating profit.
Charles River Laboratories has opened a new preclinical development facility in Shanghai, China which, the firm says, will act as a centre of excellence and help strengthen its position in the global outsourcing market.
Merck & Co has completed start-up activities at its vaccine manufacturing plant in Durham, North Carolina, which is intended to further the company’s ambitions in the sector.
A new avenue of inquiry has been opened in the investigation into the US Food and Drug Administration’s (FDA) ability and commitment to protect the nation’s citizens from unsafe drugs.
US President George W Bush has signed a bill under which counterfeiters can be sentenced to life imprisonment if their crime causes the death of an individual.
US drugmaker Par Pharmaceuticals is wielding the axe at its generics division, cutting 190 jobs and refocusing its R&D efforts on the completion of its current roster of product candidates
China’s WuXi PharmaTech has reported a below par set of unaudited third quarter results and has cut its full-year expectations blaming the current economic climate’s impact on R&D spending within the sector.
The MicroSEQ detection platform, developed by Applied Biosystems, looks set to revolutionise the detection of bacterial Mycoplasma in industrial scale biopharmaceutical manufacturing.
in-PharmaTechnologist.com presents its latest round up of developments in drug delivery, including Philips first foray into drug delivery and a licensing deal for 3M.
US company Ferro has said it will sell off its fine chemicals division to private equity firm Arsenal Capital Partners, which will rename the business as Novolyte Technologies, for $66m.
Contract research organisation PPD will have to forego a scheduled $25m payment from Takeda of Japan in the fourth quarter after the US Food and Drug Administration (FDA) held up approval of a product for diabetes.
With big pharma and biopharma looking to cut costs and increase efficiency, liquid handling experts Artel have found that their services are in greater need than ever before.
Dutch sample and assay technology expert Qiagen has continued its march into the detection system market with the acquisition of Biotage’s Biosystems business.
The 2008 Nobel Prize for Chemistry has been awarded equally to three chemists "for the discovery and development of the green fluorescent protein (GFP),” one of the most important tools in bioscience.
After months of deliberations, a court in Iowa has opted to fine contract manufacturing company Cambrex $6,000 for safety violations after an explosion at its facility in Charles City.
Contracting giant Patheon hopes that new intermediate scale, QbD compatible API manufacturing capabilities will broaden its offering to the drug industry and enable it to cement its market position.
API maker Cody Laboratories is targeting the lucrative analgesic and pain management markets with a new process that improves the efficiency of hydromorphone and hydrocodone manufacture.
US-based contract research organisation Medelis has founded a European division, Medelis Europe, to bring its expertise in oncology clinical trials design and management to customers wanting to launch drugs in Europe.
The scientists who discovered the viruses responsible for causing AIDS and cervical cancer have been honoured with the 2008 Nobel Prize in Physiology or Medicine.
GE Healthcare’s range of AxiChrom columns will simplify manufacturing operations, improve reproducibility and allow for faster change over according to company senior product manager, Per Karlberg.
Industrial polymer firm Arkema hopes that Kynar Rx, a new grade of its widely used Kynar resin technology, will help it corner the market for single-use sterile manufacturing applications in the bioprocessing sector.
Bilcare, Patheon, Pierre Fabre and Catalent were among the winners at the 2008 European Outsourcing awards, held during this year’s CPhI conference in Frankfurt, Germany.
PPD has been selected as the full-service preferred provider for translational clinical development services by the Juvenile Diabetes Research Foundation (JDRF).
The International Pharmaceutical Excipients Council (IPEC) of Europe has outlined the actions it is taking as it continues to develop awareness of the need for safe excipients.
San Diego-based biotechnology contract research organisation (CRO) Bio-Quant has expanded its animal diagnostic services offering to cover all nine species used in medical research.
Drug discovery informatics and services provider Tripos International has continued to flourish under the ownership of Vector Capital and is collaborating with AstraZeneca (AZ) to improve drug discovery workflows.
Dow Chemical is hoping to push production of its Carbowax Sentry brand of polyethylene glycol ingredients up by a third over 2006/2007 levels by the end of the year, and put the production problems of recent months behind it.
Packaging firm Chesapeake has become a visible casualty of the current economic climate, with the New York Stock Exchange (NYSE) suspending trading of its shares.
Drug delivery specialist Encap hopes that a recently completed £3m (€3.9m) expansion of its production facility, which allows it make high potency drugs, will help it attract a broader range of manufacturing contracts.
The UK launch of Eli Lilly’s pre-filled insulin device Humalog KwikPen offers the country’s 800,000 insulin-dependant diabetics a simplified treatment option, according to company development director Stuart Breslin.
BioVigilant says that two type V DMFs for its IMD-A rapid microbial detection system, which it has filed with the US FDA, can now be referenced by clients hoping to use it in drug manufacture, potentially reducing review times.
Contract research organisation Encorium has bought $250,000 of its own stock in a bid to stabilise its share price, which has been in steep decline in recent weeks.
Almac Sciences of Northern Ireland has introduced a new business unit covering solid state chemistry in a move that addresses a missing link in its technology portfolio.
Ahead of the “open house” at its facility in Monteriggioni, Siena, Italian machining specialist Marchesini spoke with in-PharmaTechnologist.com about the new plant and its role in the firm's offering to the drug industry.
Alcan says that its new Indian facility further strengthens its position “in pharmaceutical flexibles through growth in emerging markets,” which contributed about 20 per cent of its revenue last year.
in-PharmaTechnologist.com’s latest round up of developments in drug delivery includes Critical Pharmaceuticals’ sustained release hGH, Phase III results for AP Pharma and nanodiamonds.
Eli Lilly has agreed to acquire ImClone for $6.5bn and in doing so appears to have snatched the biotech away from Bristol-Myers Squibb (BMS), which first tabled a bid back in July.